Skip to main content
Top
Published in:

01-06-2025 | Metastasis | MINI REVIEW

The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability

Author: Kelvin K. Tsai

Published in: Cancer and Metastasis Reviews | Issue 2/2025

Login to get access

Abstract

Despite recent advances in targeted and immuno-therapy, metastasis still kills most cancer patients. Overcoming cancer metastasis requires a leap forward in understanding its molecular underpinnings to identify breakthrough therapeutic targets and strategies. A growing body of evidence suggests that specific subsets of cancer cells, which exhibit stem-like properties and are referred to as cancer stem cells (CSCs), are the primary drivers of cancer metastasis. How CSCs contribute to the multistep process of invasion and metastasis remains incompletely understood. Invadosomes are dynamic actin-based cellular protrusions that mediate cell invasion and pericellular proteolysis. Recent data have highlighted the highly proficient ability of CSCs to generate invadosomes, facilitating their local invasiveness, intravasation, extravasation, and metastatic colonization. This up-to-date and focused review describes the recent progress in characterizing invadosomes in embryonic cells during development and in CSCs during cancer metastasis. We summarize the molecular processes that regulate the invadosomes of CSCs. We discuss the molecules associated with the invadosome of CSCs and highlight their correlation with cancer metastasis in patients. We propose targeting the invadosomes of CSCs as a novel strategy to overcome cancer invasiveness and metastasis. This review highlights the emerging role of invadosomes in CSCs and provides a new perspective on pathobiology and cancer metastasis treatment.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
The invadosome of stem-like cancer cells: metastasis machinery and targetable vulnerability
Author
Kelvin K. Tsai
Publication date
01-06-2025
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 2/2025
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-025-10270-6

ASCO 2025 Annual Meeting

Keep up to date with the latest in oncology research with our ASCO 2025 hub page, featuring official videos, breaking news, and more.

Read more

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more